logo

For the Inventor, By the Inventor

Encinitas, CA, United States of America

Shao Song Chu

This inventor holds 5 USPTO granted patents. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 2003-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shao Song Chu. Retrieved from https://idiyas.com/inventor/shao-song-chu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Carlsbad, CA (US) (2004)
  • Encinitas, CA (US) (2003 - 2006)

Company Filing History:

goldMedal5 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents

Years Active: 2003-2006

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6989384 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2006-01-24),
2. 6720346 - Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation (2004-04-13),
3. 6632825 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis (2003-10-14),
4. 6620828 - Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use (2003-09-16),
5. 6569878 - Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors (2003-05-27),

Title: Innovator Shao Song Chu: Pioneering Antiviral Compounds in Encinitas, CA

Introduction

Shao Song Chu is a distinguished inventor based in Encinitas, California, known for his contributions to the field of antiviral research. With a total of five patents to his name, he has focused on developing innovative compounds that target viral infections, particularly those caused by picornaviruses.

Latest Patents

Among his latest patents is a groundbreaking work on antipicornaviral compounds and compositions, along with their pharmaceutical uses and synthesis materials. These compounds are designed to inhibit the activity of the picornaviral 3C protease, offering potential treatments for patients infected with various picornaviruses, including Rhinovirus. Additionally, his research has led to the development of thiazole benzamide derivatives and pharmaceutical compositions that effectively inhibit cell proliferation.

Career Highlights

Shao Song Chu has made significant strides in the pharmaceutical industry through his innovative approaches to antiviral therapies. He is currently affiliated with Agouron Pharmaceuticals, Inc., where he leverages his expertise to drive forward the development of novel antiviral treatments.

Collaborations

In his endeavors, Shao collaborates with esteemed colleagues such as Yi Yang and Siegfried Heinz Reich. Together, they push the boundaries of research, striving to find effective solutions in the fight against viral infections.

Conclusion

Shao Song Chu stands out as an influential inventor whose work has the potential to impact public health significantly. With his dedication to developing antiviral compounds and his collaborative efforts in the pharmaceutical industry, he continues to pave the way for innovative medical solutions that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…